Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 02, 2015 11:33 AM ET

Healthcare Equipment and Supplies

Company Overview of Vascular Pathways, Inc.

Company Overview

Vascular Pathways, Inc., a medical device company, focuses on the innovation and optimization of peripheral vascular access devices. It offers AccuCath Intravenous Catheter to sample blood, monitor blood pressure, or administer fluids intravenously. The company was incorporated in 2002 and is based in Naples, Florida.

1847 Trade Center Way

Naples, FL 34109

United States

Founded in 2002

Phone:

239-254-0391

Fax:

239-513-1533

Key Executives for Vascular Pathways, Inc.

Chief Executive Officer and President
Executive Chairman
Age: 56
Vice President of Clinical Affairs
Vice President of Manufacturing
Vice President of Regulatory Affairs and Quality Assurance
Compensation as of Fiscal Year 2015.

Vascular Pathways, Inc. Key Developments

Vascular Pathways Enters into Contract with Novation for AccuCath Line of Catheters

Vascular Pathways reported a new agreement with Novation for their range of AccuCath Catheters. Vascular Pathways announced that through this new agreement, members and affiliates of VHA Inc., UHC, Children's Hospital Association and Provista will have access at exclusive member rates to its proprietary line of coiled-tip wire guided catheters designed to increase first attempt success, reduce complication rates, extend dwell times, increase patient satisfaction, and lower overall costs to the provider.

Vascular Pathways, Inc. Presents at 2015 Florida Venture Capital Conference, Jan-29-2015

Vascular Pathways, Inc. Presents at 2015 Florida Venture Capital Conference, Jan-29-2015 . Venue: Diplomat Resort & Spa, Hollywood, Florida, United States.

Vascular Pathways, Inc. Names Rudy Mazzocchi Executive Chairman of Board of Directors

Vascular Pathways, Inc. announced the company has appointed Rudy Mazzocchi as Executive Chairman of their Board of Directors. Rudy Mazzocchi has over 25 years of senior management, technology development and financing experience in the medical devices industry. Rudy Mazzocchi has over 25 years of senior management, technology development and financing experience in the medical devices industry. Rudy currently serves as CEO of ELENZA (an Implantable Electro-active Intraocular Lens technology) and previously served as the Interim-CEO of NovaVision Inc.

Similar Private Companies By Industry

Company Name Region
Noraxon U.S.A., Inc. United States
Fitzco, Inc. United States
Suspension Orthopaedic Solutions, LLC United States
Avitar Technologies, Inc. United States
IYIA Technologies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vascular Pathways, Inc., please visit www.vascularpathways.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.